Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian Markets open on a dull note
Tue, 14 Jul 09:30 am

The major Asian stock markets have opened the session on a mixed note with markets in Hong Kong (down 0.6 %) and China (down 0.3%) leading the losses. However, markets in Japan are trading in the green, up by 1.6%. US and European stock markets closed their session on an encouraging note yesterday. The rupee is trading in green at 63.55 per US dollar.

Indian stock markets today have opened on a flat note BSE-Sensex is trading down by 32 points (down 0.1%) and NSE-Nifty is trading down by 8 points (down 0.1%). S&P BSE Midcap and S&P BSE Smallcap index indices are trading marginally, up by 0.1% and 0.4% respectively. Sectoral indices are trading mixed with stocks in energy and auto bearing maximum burnt.

Stocks in the pharma space have opened their day on a mixed note. As per the leading financial daily, Cipla has received an approval for divestment of its consumer healthcare business to a wholly owned subsidiary. This divestment will be on a going-concern basis by way of slump sale for a consideration of Rs 105 m. the same has been approved by the company's board of directors at the meeting held on 9th of July. The said divestment would enable the company to participate in the attractive & growing over-the-counter (OTC) market. For the last quarter of 2014-15, the turnover contributed by the OTC division stood at Rs 348 m. The net worth of OTC division of the company as on March 31, 2015 was Rs 64.5 m contributing 0.06% of the net worth of the company. Stock of Cipla has opened the day on an encouraging note.

According to financial times, Sintex Industries has declared its results for the first quarter ended June 30, 2015. On the standalone basis, the total income stood increased by 7.7% on a YoY (year-on-year) basis. The net profits were up by 12.6% YoY for the same quarter On the consolidated basis, the company's total income was up by 10.5% YoY and profits for same period were up by 12% YoY. Stock of Sintex Industries has opened the day on a firm note.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian Markets open on a dull note". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.